Miller Anestesia

214. Hatano Y, Arai T, Noda J, et al: Contribution of

prostacyclin to

-tubocurarine–induced hypoten-

sion in humans. Anesthesiology 72:28–32, 1990.

215. Scott RP, Savarese JJ, Basta SJ, et al: Atracurium:

Clinical strategies for preventing histamine release

and attenuating the haemodynamic response. Br J

Anaesth 57:550–553, 1985.

216. Savarese JJ: The autonomic margins of safety of

metocurine and

-tubocurarine in the cat.Anesthe-

siology 50:40–46, 1979.

217. Naguib M, Samarkandi AH, Bakhamees HS, et al:

Histamine-release haemodynamic changes produ-

ced by rocuronium, vecuronium, mivacurium, atra-

curium and tubocurarine. Br J Anaesth 75:588–592,

1995.

218. Miller RD, Eger EI 2nd, Stevens WC, Gibbons R:

Pancuronium-induced tachycardia in relation to

alveolar halothane, dose of pancuronium, and prior

atropine. Anesthesiology 42:352–355, 1975.

219. Docherty JR,McGrath JC: Sympathomimetic effects

of pancuronium bromide on the cardiovascular

system of the pithed rat: A comparison with the

effects of drugs blocking the neuronal uptake of

noradrenaline. Br J Pharmacol 64:589–599, 1978.

220. Roizen MF, Forbes AR, Miller RD, et al: Similarity

between effects of pancuronium and atropine on

plasma norepinephrine levels in man. J Pharmacol

Exp Ther 211:419–422, 1979.

221. Reitan JA, Fraser AI, Eisele JH: Lack of cardiac ino-

tropic effects of gallamine in anesthetized man.

Anesth Analg 52:974–979, 1973.

222. Wong KC, Wyte SR, Martin WE, Crawford EW:

Antiarrhythmic effects of skeletal muscle relaxants.

Anesthesiology 34:458–462, 1971.

223. Geha DG, Rozelle BC, Raessler KL, et al: Pancuro-

nium bromide enhances atrioventricular conduc-

tion in halothane-anesthetized dogs.Anesthesiology

46:342–345, 1977.

224. Edwards RP, Miller RD, Roizen MF, et al: Cardiac

responses to imipramine and pancuronium during

anesthesia with halothane or enflurane.Anesthesio-

logy 50:421–425, 1979.

225. Clayton D: Asystole associated with vecuronium. Br

J Anaesth 58:937–938, 1986.

226. Starr NJ, Sethna DH, Estafanous FG: Bradycardia

and asystole following the rapid administration of

sufentanil with vecuronium. Anesthesiology

64:521–523, 1986.

227. Cozanitis DA, Erkola O: A clinical study into the

possible intrinsic bradycardic activity of vecuro-

nium. Anaesthesia 44:648–650, 1989.

228. Bonner TI, Young AC, Brann MR, Buckley NJ:

Cloning and expression of the human and rat m

muscarinic acetylcholine receptor genes. Neuron

1:403–410, 1988.

229. Mak JC, Barnes PJ: Autoradiographic visualization

of muscarinic receptor subtypes in human and

guinea pig lung.Am Rev Respir Dis 141:1559–1568,

1990.

230. Coulson FR, Fryer AD: Muscarinic acetylcholine

receptors and airway diseases. Pharmacol Ther

98:59–69, 2003.

231. Jooste E, Klafter F, Hirshman CA, Emala CW: A

mechanism for rapacuronium-induced bronchos-

pasm: M

muscarinic receptor antagonism. Anes-

thesiology 98:906–911, 2003.

232. Naguib M: How serious is the bronchospasm

induced by rapacuronium? Anesthesiology 94:924–

925, 2001.

233. Meakin GH, Pronske EH, Lerman J, et al: Bronchos-

pasm after rapacuronium in infants and children.

Anesthesiology 94:926–927, 2001.

234. Kron SS: Severe bronchospasm and desaturation in

a child associated with rapacuronium. Anesthesio-

logy 94:923–924, 2001.

235. Laxenaire MC, Moneret-Vautrin DA, Widmer S,

et al: [Anesthetics responsible for anaphylactic

shock.A French multicenter study.].Ann Fr Anesth

Reanim 9:501–506, 1990.

236. Fisher MM, More DG: The epidemiology and clini-

cal features of anaphylactic reactions in anaesthesia.

Anaesth Intensive Care 9:226–234, 1981.

237. Mertes PM, Laxenaire MC,Alla F:Anaphylactic and

anaphylactoid reactions occurring during anesthe-

sia in France in 1999-2000. Anesthesiology 99:536–

545, 2003.

238. Baldo BA, Fisher MM: Substituted ammonium ions

as allergenic determinants in drug allergy. Nature

306:262–264, 1983.

239. Levy JH, Davis GK, Duggan J, Szlam F: Determina-

tion of the hemodynamics and histamine release of

rocuronium (Org 9426) when administered in

increased doses under N

O/O

-sufentanil anesthe-

sia. Anesth Analg 78:318–321, 1994.

240. Rose M, Fisher M: Rocuronium: High risk for ana-

phylaxis? Br J Anaesth 86:678–682, 2001.

241. Watkins J: Incidence of UK reactions involving

rocuronium may simply reflect market use. Br J

Anaesth 87:522, 2001.

242. Mertes PM, Moneret-Vautrin DA, Leynadier F,

Laxenaire MC: Skin reactions to intradermal neu-

romuscular blocking agent injections: A randomi-

zed multicenter trial in healthy volunteers.

Anesthesiology 107:245–252, 2007.

243. Laxenaire MC, Mertes PM: Anaphylaxis during

anaesthesia. Results of a two-year survey in France.

Br J Anaesth 87:549–558, 2001.

244. Levy JH, Gottge M, Szlam F, et al: Wheal and flare

responses to intradermal rocuronium and cisatra-

curium in humans. Br J Anaesth 85:844–849,

2000.

245. Futo J, Kupferberg JP, Moss J, et al: Vecuronium

inhibits histamine

-methyltransferase. Anesthe-

siology 69:92–96, 1988.

246. O’Callaghan AC, Scadding G, Watkins J: Bronchos-

pasm following the use of vecuronium.Anaesthesia

41:940–942, 1986.

247. Naguib M, Magboul MM, Jaroudi R: Clinically sig-

nificant drug interactions with general anesthetics

—incidence, mechanims and management. CNS

Drugs 8:51–78, 1997.

248. Miller RD: Factors affecting the action of muscle

relaxants. In Katz RL (ed): Muscle Relaxants. Ams-

terdam, Excerpta Medica, 1975.

249. Naguib M,Abdulatif M, al-Ghamdi A, et al: Interac-

tions between mivacurium and atracurium. Br J

Anaesth 73:484–489, 1994.

250. Lebowitz PW, Ramsey FM, Savarese JJ, et al: Com-

bination of pancuronium and metocurine: Neuro-

muscular and hemodynamic advantages over

pancuronium alone. Anesth Analg 60:12–17,

1981.

251. Paul M, Kindler CH, Fokt RM, et al: Isobolographic

analysis of non-depolarising muscle relaxant inte-

ractions at their receptor site. Eur J Pharmacol

438:35–43, 2002.

252. Motamed C, Menad R, Farinotti R, et al: Potentia-

tion of mivacurium blockade by low dose of pan-

curonium:Apharmacokineticstudy.Anesthesiology

98:1057–1062, 2003.

253. Kay B, Chestnut RJ, Sum Ping JS, Healy TE:

Economy in the use of muscle relaxants. Vecuro-

nium after pancuronium. Anaesthesia 42:277–280,

1987.

254. Rashkovsky OM, Agoston S, Ket JM: Interaction

between pancuronium bromide and vecuronium

bromide. Br J Anaesth 57:1063–1066, 1985.

255. Katz RL: Modification of the action of pancuro-

nium by succinylcholine and halothane. Anesthe-

siology 35:602–606, 1971.

256. Ono K, Manabe N, Ohta Y, et al: Influence of suxa-

methonium on the action of subsequently adminis-

tered vecuronium or pancuronium. Br J Anaesth

62:324–326, 1989.

257. Katz JA, Fragen RJ, Shanks CA, et al: The effects of

succinylcholine on doxacurium-induced neuro-

muscular blockade. Anesthesiology 69:604–607,

1988.

258. Cooper R,Mirakhur RK,Clarke RS,Boules Z: Com-

parison of intubating conditions after administra-

tionof Org9246(rocuronium)andsuxamethonium.

Br J Anaesth 69:269–273, 1992.

259. Kelly RE, Lien CA, Savarese JJ, et al: Depression of

neuromuscular function in a patient during desflu-

rane anesthesia. Anesth Analg 76:868–871, 1993.

260. Saitoh Y, Toyooka H, Amaha K: Recoveries of post-

tetanic twitch and train-of-four responses after

administration of vecuronium with different inha-

lation anaesthetics and neuroleptanaesthesia. Br J

Anaesth 70:402–404, 1993.

261. Miller RD, Way WL, Dolan WM, et al: The depen-

dence of pancuronium- and

-tubocurarine–

induced neuromuscular blockades on alveolar

concentrations of halothane and forane. Anesthe-

siology 37:573–581, 1972.

262. Miller RD, Crique M, Eger EI 2nd: Duration of

halothane anesthesia and neuromuscular blockade

with

-tubocurarine. Anesthesiology 44:206–210,

1976.

263. Rupp SM, Miller RD, Gencarelli PJ: Vecuronium-

induced neuromuscular blockade during enflurane,

isoflurane, and halothane anesthesia in humans.

Anesthesiology 60:102–105, 1984.

264. Gencarelli PJ, Miller RD, Eger EI 2nd, Newfield P:

Decreasing enflurane concentrations and

-tubocu-

rarine neuromuscular blockade. Anesthesiology

56:192–194, 1982.

265. Miller RD, Way WL, Dolan WM, et al: Comparative

neuromuscular effects of pancuronium, gallamine,

and succinylcholine during forane and halothane

anesthesia in man. Anesthesiology 35:509–514, 1971.

266. Wulf H, Ledowski T, Linstedt U, et al: Neuromuscu-

lar blocking effects of rocuronium during desflu-

rane, isoflurane, and sevoflurane anaesthesia. Can J

Anaesth 45:526–532, 1998.

267. Bock M, Klippel K, Nitsche B, et al: Rocuronium

potency and recovery characteristics during steady-

state desflurane, sevoflurane, isoflurane or propofol

anaesthesia. Br J Anaesth 84:43–47, 2000.

268. Paul M, Fokt RM, Kindler CH, et al: Characteriza-

tion of the interactions between volatile anesthetics

and neuromuscular blockers at the muscle nicotinic

acetylcholine receptor. Anesth Analg 95:362–367,

2002.

269. Pereon Y, Bernard JM, Nguyen The Tich, et al: The

effects of desflurane on the nervous system: From

spinal cord to muscles. Anesth Analg 89:490–495,

1999.

270. Franks NP, LiebWR: Molecular and cellular mecha-

nisms of general anaesthesia. Nature 367:607–614,

1994.

271. Burkett L, Bikhazi GB, Thomas KC Jr, et al: Mutual

potentiation of the neuromuscular effects of anti-

biotics and relaxants. Anesth Analg 58:107–115,

1979.

272. Hasfurther DL, Bailey PL: Failure of neuromuscular

blockade reversal after rocuronium in a patient who

received oral neomycin. Can J Anaesth 43:617–620,

1996.

273. Heier T, Caldwell JE, Sessler DI, Miller RD: Mild

intraoperative hypothermia increases duration of

action and spontaneous recovery of vecuronium

blockade during nitrous oxide–isoflurane anesthe-

sia in humans. Anesthesiology 74:815–819, 1991.

274. Leslie K, Sessler DI, Bjorksten AR, Moayeri A: Mild

hypothermia alters propofol pharmacokinetics and

increases the duration of action of atracurium.

Anesth Analg 80:1007–1014, 1995.

275. Caldwell JE,Heier T,Wright PM,et al: Temperature-

dependent pharmacokinetics and pharmacodyna-

mics of vecuronium. Anesthesiology 92:84–93,

2000.

276. Heier T, Caldwell JE, Sessler DI, et al: The relation-

ship between adductor pollicis twitch tension and

core, skin, and muscle temperature during nitrous

oxide–isoflurane anesthesia in humans.Anesthesio-

logy 71:381–384, 1989.

Farmacología de los relajantes musculares y sus antagonistas

673

Sección II

Farmacología y anestesia